Which patients with unprovoked VTE should receive extended anticoagulation? the minority

By Donadini Marco   Ageno Walter  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 301-305

Springer Publishing Company

Access to resources Recommend Favorite

Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

By Donadini Marco   Douketis James  

Journal of Thrombosis and Thrombolysis, Vol. 29, Iss. 2, 2010-02 ,pp. : 208-213

Springer Publishing Company

Access to resources Recommend Favorite

All patients with ‘idiopathic’ hypopituitarism should be screened for hemochromatosis

By Lewis Anthony   Courtney C.   Atkinson A.  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 273-275

Springer Publishing Company

Access to resources Recommend Favorite

Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?

By Clase Catherine M.   Holden Rachel M.   Sood Manish M.   Rigatto Claudio   Moist Louise M.   Thomson Benjamin K. A.   Mann Johannes F. E.   Zimmerman Deborah L.  

Nephrology Dialysis Transplantation, Vol. 27, Iss. 10, 2012-10 ,pp. : 3719-3724

Oxford University Press

Access to resources Recommend Favorite

Transcatheter arterial embolization should be the salvage treatment of choice in all patients with bleeding from duodenal ulcers resistant to endoscopic hemostasis

By Loffroy Romaric  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 7-8, 2010-08 ,pp. : 1003-1004

Informa Healthcare

Access to resources Recommend Favorite